ZELBORAF for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where ZELBORAF was used for Neoplasm malignant.
Most Reported Side Effects for ZELBORAF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 62 | 17.3% | 29 | 4 |
| Death | 49 | 13.7% | 49 | 4 |
| Rash | 45 | 12.6% | 4 | 10 |
| Arthralgia | 29 | 8.1% | 2 | 9 |
| Fatigue | 17 | 4.8% | 3 | 8 |
| Nausea | 16 | 4.5% | 3 | 10 |
| Asthenia | 14 | 3.9% | 2 | 4 |
| Dysphagia | 14 | 3.9% | 1 | 4 |
| Erythema | 14 | 3.9% | 4 | 2 |
| Photosensitivity reaction | 14 | 3.9% | 3 | 4 |
| Pyrexia | 13 | 3.6% | 1 | 6 |
| Diarrhoea | 12 | 3.4% | 4 | 6 |
| Pain in extremity | 12 | 3.4% | 1 | 5 |
| Drug ineffective | 11 | 3.1% | 6 | 3 |
| Malignant neoplasm progression | 11 | 3.1% | 7 | 2 |
Other Indications for ZELBORAF
Metastatic malignant melanoma (130)
Malignant melanoma (109)
Product used for unknown indication (90)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)